By Chris Hutching
|
Friday 22nd November 2002 |
Text too small? |
Brokers said investors keen on the stock had already bought shares in recent months when the price reached a high of 20c. Listed Southern Capital, another in Mr Paterson's stable, owns 4.3% of the 166,666,666 shares on issue bought at 10c a share.
Botry-Zen manufactures a biological control against fruit fungus Botrytis cinerea, which often affects grapevines. The company forecasts sales of $1.2 million next year and a $135,000 profit in the year to March 31, 2004, but expects a $926,000 shortfall this year as it sets up operations.
Botry-Zen was initially floated last year to private investors in a $5 million capital raising. In July it was granted registration for grape application under the Pesticides Act.
No comments yet
SCT - 2026 Half Year Announcement
Devon Funds Morning Note - 14 April 2026
BNP Paribas accredited as Derivatives Market Maker
GXH - Response to media report
April 14th Morning Report
SML - Synlait responds to The a2 Milk Company announcement
KPG - Annual meeting date, closing date for director nominations
April 13th Morning Report
CVT - Update on banking facilities
April 9th Morning Report